Press Release AlivaMab Biologics and Ablexis Congratulate Boulevard Bio on its Launch and the Ongoing Phase 1 Clinical Trial of Bispecific Antibody BLVD101 AlivaMab Biologics, LLC · Aug 13
Press Release United Way of Greater St. Louis: The Power of Partnership United Way of Greater St. Louis · Aug 13
Press Release AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency Aimwell Partners · Aug 13
Press Release Viking Capital Q2 Report: Multifamily Enters a Year of Normalization as Supply Falls and Capital Awaits the Right Entry Point Viking Capital Investments LLC · Aug 13
Press Release RenX Enterprises Corp. Reports Second Quarter 2026 Results: Record Quarterly Revenue of $4.26 Million, Logistics Segment Profitable for Second Consecutive Quarter RenX Enterprises Corp · Aug 13
Press Release Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances Ainos, Inc. · Aug 13
Press Release Sibannac, Inc. (OTCID:SNNC) Enters Into Non-Binding Letter of Intent for Strategic Collaboration and Potential Reverse Merger Focused on Advancing Patient Health Potential Sibannac, Inc. · Aug 13
Press Release BioAdaptives, Inc. Announces CEO’s Share Cancellation and Provides Capital Restructure Update BioAdaptives, Inc. · Aug 13
Press Release 374Water and Arcadis Team Receives U.S. Department of Defense Success Memo Opening Pathway for AirSCWO(TM) Technology for PFAS Destruction at Commercial Scale 374Water Inc. · Aug 13
Press Release Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th Aspire Biopharma Holdings, Inc. · Aug 13